# Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Canonical URL: https://biopharmsignal.com/news/ANNX/annexon-reports-inducement-grant-to-new-employee-under-nasdaq-listing-rule-5635-c-4
Ticker: ANNX
Company: Annexon, Inc.
Source: Annexon, Inc.
Published: 2026-03-16 20:05 EST
Original Source URL: https://ir.annexonbio.com
## Summary

BRISBANE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted

## Article Body
BRISBANE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted
## Recent Company News
- 2026-05-27 12:00 EST — [Annexon to Participate in Upcoming June Investor Conferences](https://biopharmsignal.com/news/ANNX/annexon-to-participate-in-upcoming-june-investor-conferences) — Source: Annexon, Inc.
- 2026-05-07 20:01 EST — [Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones](https://biopharmsignal.com/news/ANNX/annexon-reports-first-quarter-2026-financial-results-portfolio-progress-and-key-anticipated-milestones) — Source: Annexon, Inc.
- 2026-05-06 12:00 EST — [Annexon to Present at the Bank of America Securities Health Care Conference 2026](https://biopharmsignal.com/news/ANNX/annexon-to-present-at-the-bank-of-america-securities-health-care-conference-2026) — Source: Annexon, Inc.
- 2026-04-08 20:05 EST — [Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/ANNX/annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Annexon, Inc.
- 2026-03-30 20:01 EST — [Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones](https://biopharmsignal.com/news/ANNX/annexon-reports-fourth-quarter-and-year-end-2025-financial-results-portfolio-progress-and-key-anticipated-milestones) — Source: Annexon, Inc.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)